PubMed Health⌕ Search

PubMed · 15876837

Challenges in interventional nephrology.

Abstract

Lately, there has been a progressive decrease in the interest of nephrology as a medical sub-specialty reflected primarily in the decreasing number of renal fellows. Rising costs in establishing and running dialysis clinics and the lost of nephrologic procedures previously performed by nephrologists are among the many reasons for this disillusionment with the specialty. The care of chronic kidney patients frequently involve many diagnostic and interventional radiological procedures such as: diagnostic renal ultrasonography, ultrasound-guided kidney biopsies, placement of tunneled hemodialysis catheters or peritoneal catheters, sonographic and radiological investigation of vascular access dysfunction, etc. Most of these procedures are nowadays performed by radiologists, vascular surgeons and surgeons in general. This fragmentation does not optimize medical care and it is inconvenient to the patient. This has led many nephrologists to introduce a new paradigm in kidney patients management, often referred as interventional nephrology (IN). This new breed of nephrologists have acquired diagnostic and interventional skills for procedures usually done by others with an added clinical perspective. To train nephrologists in these procedures and avoid the fragmented care of renal patients, the American Society for Diagnostic and Interventional Nephrology was established in 2000 and the International Society of Nephrology in 2004 introduced a new committee to address the issues of IN. It is hoped that concerted efforts will help to rescue these activities for the nephrologists and improve quality of patient care.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Miguel C Riella. 2005. Challenges in interventional nephrology.. https://doi.org/10.1159/000085476

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗